Avivagen Inc V.VIV.H

the testing and order was for dairy

[StoneMan45]

This significant order comes as the result of two positive tests of OxC-beta™ Livestock under Mexican commercial dairy production conditions. Both tests were conducted by a dairy farm that is a customer of Industrias Melder. The tests ran for 42 days and evaluated OxC-beta for the ability to improve animal health, productivity and milk quality. In the first test, conducted with a group of the farm’s best producing cows, there were improvements in the both the quantity and quality of milk produced. The largest impact was a 54% reduction in the farm’s bulk tank milk-somatic cell count. The somatic cell count of a farm’s bulk milk reservoir is a widely recognized indicator of milk quality and farms commonly receive financial incentives or premiums for milk with lower somatic cell counts. There was also a benefit on animal health as indicated by reduced somatic cell counts from milk sampled from individual animals. Of significant note, a large and well known global dairy processor that purchases the farm’s milk recognized the farm with three separate financial awards for the improvements in milk yield, quality, and reduced bacterial levels achieved during the test.

At the conclusion of the first test a second test was conducted at the same site on a separate group of cows with chronic health, productivity and milk quality challenges. The results of the second test were largely consistent with those observed for the first trial. Namely, increased milk quality stemming from an improvement in overall animal health. As in the first test the benefit of using OxC-beta was most evident on the bulk tank milk-somatic cell count, which was greatly reduced (67%) during the second test. There was also an 8% increase in the number of animals categorized as “healthy” by the attending veterinarian. This was an important finding given the suboptimal health status of this group of animals at the beginning of the test.